Texas Attorney General Ken Paxton has launched an investigation into Blue Cross Blue Shield of Texas, its parent company Health Care Service Corporation, and related entities over allegations that the insurer denied or delayed coverage for medically necessary and urgent care. Among the claims under scrutiny: a report that administrative denials delayed a newborn's transfer to a facility equipped to treat the baby, even though the procedure was allegedly covered under the family's health plan.
The investigation was detailed in a Civil Investigative Demand issued by Paxton's office, as reported by Click2Houston. The demand seeks information about whether BCBSTX, HCSC, or related entities violated Texas law, including potential violations of the Texas Deceptive Trade Practices Act. According to the outlet, the Office of the Attorney General said it received reports alleging that BCBSTX's prior authorization and utilization review procedures created delays in approving treatment.
Paxton did not mince words about the stakes involved. “Blue Cross Blue Shield should put patients before profits and help provide urgently needed care,” he said, per the same report. His office has said delays in urgent treatment can increase the risk of complications, allow diseases to progress, and in the worst cases result in disability or death — while also driving up administrative costs.
What Investigators Are Trying to Determine
The inquiry will examine BCBSTX's public representations about how it approves and denies medically necessary claims, and whether claims were rejected without adequate review, the report notes. Investigators are also looking at whether the companies engaged in other unlawful practices beyond the specific allegations already surfaced.
A nationwide Conduent cybersecurity incident affected more than 25 million people, with Texas taking the heaviest hit of any state, according to Hoodline.
A Pattern of Insurer Scrutiny Across Texas
BCBSTX is no small target. It is the largest health plan provider in Texas and the state's only statewide customer-owned insurer, serving more than 10 million members across all 254 counties, according to Solace. Its parent is Health Care Service Corporation.
Paxton's investigation centers on allegations involving health insurers' claims and review practices.
The scrutiny extends beyond Texas regulators, too. In September, three HCA Houston Healthcare hospitals and Methodist Healthcare System of San Antonio filed a federal lawsuit against Independence Blue Cross, accusing the insurer of unlawful prior authorization barriers and emergency claim denials, as reported by Healthcare Dive. The hospital networks allege the insurer failed to provide required clinical rationales and refused proper medical necessity reviews.
Texas's Prior Authorization Fight Isn't New
Texas has tried to rein in prior authorization delays before. The state passed House Bill 3459, known as the Gold Card law, in 2021 and expanded it with HB 3812 in 2025, exempting physicians who achieve a 90% prior authorization approval rate over six months from preauthorization requirements on certain treatments, according to the Texas Department of Insurance. It became a national model for prior authorization reform in other states.
Yet the administrative burden persists nationally. An American Medical Association survey released in April 2025 found that medical practices complete an average of 39 prior authorization requests per physician every week. Digital rights advocates have raised fresh alarm this month over a federal pilot program, the Wasteful and Inappropriate Service Reduction model, which launched in six states including Texas in January to test AI-driven prior authorization. The Electronic Frontier Foundation criticized the model in September for increasing care delays across the 17 outpatient procedures it covers.
The Texas Deceptive Trade Practices Act is among the laws Paxton's office is examining.
It remains to be seen how BCBSTX will respond to the newest Civil Investigative Demand or whether the company will issue a formal defense of its prior authorization timelines.
